Navigation Links
Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
Date:7/9/2008

rs."

About Pacira

Pacira is an acute care specialty pharmaceutical company with a primary focus on developing products which satisfy the needs of our customers in the institutional marketplace. The Company utilizes DepoFoam(R) delivery technology to cost-effectively improve patient care through enhanced dosing and administration profiles. Currently, the Company is developing DepoBupivacaine(TM) in phase III clinical studies for postsurgical pain. Revenues are generated from two approved products which are marketed by partners: DepoCyt(R) for lymphomatous meningitis and DepoDur(R) for post-surgical pain. Additional information about Pacira is available at http://www.pacira.com.

This press release contains forward looking statements, which involve risks and uncertainties within the meaning of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ materially from the forward looking statements discussed in this press release. These forward looking statements include risks and uncertainties that current or future collaboration will prove to be commercially successful.


'/>"/>
SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
2. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
3. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)... -- PharmAthene, Inc.,(NYSE Alternext US: PIP), a...sures against biological and chemical threats, ann... Medison Pharma Ltd., to commercialize its,biodef...vanced medical countermeasures to combat the risk ...weapons is a significant global,concern," stated ...
(Date:11/19/2008)...ll/ -- Jazz Pharmaceuticals,Inc. (Nasdaq: JAZZ...resentation,planned for today at the Lazard Capit...o the proximity of the release of preliminary top-...al trial of JZP-6 (sodium oxybate) for,the treatm...tes that it will release the preliminary top-line ...
(Date:11/19/2008)... Therapeutics Inc., a,privately-held biotechnolog...e,hydrolase (s-EH) inhibitors, today announced th...A financing. Frazier Healthcare Ventures and Alta,...also included existing,investors Burrill & Co...nce,Ventures. This financing completes the Serie...
(Date:11/19/2008)...irstCall/ -- In a campaign,to significantly reduc...the,Mexican Public Health Agency (Secretaria de S...rst phase of a program that will offer testing for... cervical cancer, to low-income,women age 35-65. ...ncy. In,the first phase of the screening program,...
Breaking Biology Technology:PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 2PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 3PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel 4Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing 2Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 2Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 3Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 4Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer 5
...le for businesses that don,t adapt easily to an en...ate branding. , ,Local businesses such as restaura...ed and outmarketed online by larger competitors. ,...rs, physicians, and consultants struggle to adapt ...ernet. , ,Commission-driven sales organizations su...
Milwaukee Rockwell Automation Inc. has increased the quarterly dividend on its common stock to 22.5 cents per share, up from 16.5 cents, effective May 16. , ,Chairman and CEO Keith Nosbusch said t
... county businesses will receive funding for their ...ment of Commerce Technology Assistance Grant pro... will receive $11,250 to assist in its development...any will use this award to finish a patent-filing ...ff, we have not had the benefit of WARF to compl...
...nics of raising capital for your business ", when ...company should do is prepare a business plan. The ...rivate placement memorandum (PPM), the disclosure .... , ,Once the company has a good draft of the bus...(e.g., the company management, attorneys, accounta...
Other Biology Technology:Succeeding online without a Web site 2Succeeding online without a Web site 3Succeeding online without a Web site 4Due diligence and corporate clean-up 2Due diligence and corporate clean-up 3Due diligence and corporate clean-up 4
(Date:11/19/2008)...compounds created by a University of Central Flori...ast cancer tumors. , Associate Professor James T...d of breast cancer tumors in tests on mice. The c...-causing protein called STAT3, and researchers hav...he compounds are very promising," Turkson said. "T...
(Date:11/19/2008)... most reliable indicators to predict that a person...nsulin resistance. Insulin is produced in the panc...hat glucose reaches several tissues and organs in ...haracterized by the lack of tissue response to ins...f insulin by the pancreas. When the pancreas does ...
(Date:11/18/2008)...less ButtKicker(R) Kit to be Released by Amazon.co...v. 17 The Guitammer Company announ...(R) Kit for home theater, gaming and music. The ne... do-it-yourself product for home theater and gamin...urniture to become part of an affordable "4-D" the...
(Date:11/18/2008)...SWICK, N.J. Families gathering around the Thanksg...e dish that,s been given some "upscale" breeding ...age-old staple will look or taste no different tha...ing growers increase production and improve fruit ...ing them meet the increasing year-round demand for...
Breaking Biology News(10 mins):2 new compounds show promise for eliminating breast cancer tumors 2Researchers at IRB Barcelona produce more data on key genes in diabetes 2Researchers at IRB Barcelona produce more data on key genes in diabetes 3Photos: Turn Your Couch into a 'Disney' Ride for Under $300 2Photos: Turn Your Couch into a 'Disney' Ride for Under $300 3Favorite Thanksgiving dish gets 'upscale' breeding 2Part of the in group 3F A surprising new strategy helps reduce unhealthy behaviors 25712 1Part of the in group 3F A surprising new strategy helps reduce unhealthy behaviors 25712 2Operations research promises continued gains for HIV treatment in resource limited countries 25709 1Operations research promises continued gains for HIV treatment in resource limited countries 25709 2Operations research promises continued gains for HIV treatment in resource limited countries 25709 3The big gulp 3A consumers avoid extremes in soda sizes 25706 1The big gulp 3A consumers avoid extremes in soda sizes 25706 2Actuaries to Host Forum on Public Pension Disclosures 25703 1Actuaries to Host Forum on Public Pension Disclosures 25703 2Actuaries to Host Forum on Public Pension Disclosures 25703 3
... at Memorial Sloan-Kettering Cancer Center have di... stage clinical trials -- work best in patients wi...hat plays a central role in the growth and surviva...f patients with melanoma and in a minority of pati...dings, available in an advance online publication ...
...k in Current Biology, tsunami damage to coral reef...aman earthquake was occasionally spectacular, but ...o damage from chronic human misuse in the region. ...r 26, 2004, a team of ecologists from James Cook U...esia Program, and Syiah Kuala University visited a...
... would help stave off an imminent global extinctio...y in the Proceedings of the National Academy of Sc... working with the 52 member organizations of the A...tion.org ), the study identifies 794 species threa...n need of urgent conservation action at a single r...
... as containers by prehistoric peoples were likely ...ndividuals who arrived from Asia, according to a n... gourds found at archaeological sites in the Weste...rchaeological enigma by explaining how a domestica... millennia ago in places as far removed as modern-...
Other Biology News:Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs 2New study pinpoints epicenters of Earth's imminent extinctions 2Ancient humans brought bottle gourds to the Americas from Asia 2
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH
Mouse polyclonal antibody raised against a partial recombinant CSRP3. NCBI Entrez Gene ID = 8048
LTQ XL Linear Ion Trap from Thermo Scientific
Biology Products: